The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

1 Jun 2015 07:00

RNS Number : 7164O
Fastnet Oil & Gas PLC
01 June 2015
 

1 June 2015

Fastnet Oil & Gas plc

("Fastnet" or the "Company")

 

Corporate Update

 

Fastnet (AIM: FAST, ESM: FOI), the UK and Irish listed E&P company focused on near-term exploration and appraisal acreage in Morocco and the Celtic Sea, provides the following corporate update.

 

Highlights:

Significant reduction in G&A, with overhead down over 40% since the end of 2014, with further reductions expected.Cash on the balance sheet of USD$16.2 million at 31 May 2015.The Company continues to evaluate M&A opportunities capable of delivering significant shareholder value.Discussions have commenced with the Department of Communications, Energy and Natural Resources following the expiration of licensing options on 31 May 2015 of 12/2 ("Molly Malone") and 12/3 ("Mizzen").Applications have been submitted for new licensing options over high-graded portions of the previous Mizzen and Molly license areas.

 

Corporate

Fastnet provides the following update on the Molly Malone and Mizzen licensing options in the Celtic Sea (together the "Options"). In the absence of Fastnet having committed to certain additional obligations including drilling, the Options expired on 31 May 2015.

Fastnet has today submitted applications for new licensing options over portions of the original licensing option areas. The new licensing option areas were high-graded based on the technical evaluation carried out since the original licensing options were first awarded. The Minister of State at the Department of Communications, Energy and Natural Resources will consider applications received in respect of these areas in the coming months and the Company will provide an update on this process when more information is available. 

Fastnet remains excited by the quality of its Celtic Sea portfolio and will continue to technically evaluate and high-grade its acreage in the Celtic Sea. Numerous prospects and leads have been extensively mapped over the last 6 months based on newly acquired and reprocessed seismic data throughout the currently held option areas. The Company is in the process of compiling new resource estimates for the portfolio of prospects and leads.

The Company also continues to evaluate M&A opportunities in the current market environment which will deliver significant shareholder value while focussing on developing its Celtic Sea portfolio.

 

Financial

The Company has undergone a comprehensive review of general and administration costs and has reduced overheads by over 40% since December 2014 to $1.9m a year. Further corporate and overhead costs reductions are ongoing.

The Company's cash balance at 31 May 2015 was $16.2 million.

 

Carol Law, CEO of Fastnet, commented:

"We have been conducting detailed due diligence on a number of merger and acquisition opportunities in the sector, but as of yet have not identified one which would be accretive to shareholders and therefore be a suitable use of our available cash. We have taken steps to preserve our cash through reducing ongoing costs and have nearly halved our G&A expenses since the end of 2014. In the immediate future we will continue to scrutinize costs to further reduce overhead and evaluate targeted merger and acquisition opportunities aimed at enhancing value for our shareholders."

 

For further information please contact:

Fastnet Oil & Gas plc

+353 (1) 644 0007

Carol Law, Chief Executive Officer

 

Cathal Friel, Non-Executive Chairman

 

 

 

Shore Capital

+44 (0) 20 7408 4090

Nomad

 

Bidhi Bhoma, Edward Mansfield

 

 

 

Corporate Broking

 

Jerry Keen

 

 

 

Davy

+353 (1) 679 6363

(ESM Adviser & Joint Broker)

 

John Frain, Anthony Farrell

 

 

 

Camarco

+44 (0) 20 3757 4980

Billy Clegg, Georgia Mann

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEIFMUFISESI
Date   Source Headline
7th Jan 20197:00 amRNSPositive results for gene therapy AP103
4th Jan 201912:56 pmRNSEASE Phase III trial interim efficacy results
21st Dec 20182:05 pmRNSSecond Price Monitoring Extn
21st Dec 20182:00 pmRNSPrice Monitoring Extension
19th Dec 20187:00 amRNSUpdate on ongoing AP101 Trial
10th Dec 201811:30 amRNSGrant Funding from Irish Government for AP103
17th Oct 20187:00 amRNSLojuxta to be reimbursed in France
26th Sep 20187:00 amRNSInterim Results
14th Sep 20187:00 amRNSNotice of Results
10th Sep 20187:00 amRNSAmryt receives IND approval from FDA for AP101
2nd Aug 20187:00 amRNSFDA grants Pediatric Rare Disease designation
19th Jul 20187:00 amRNSTrading update & significant momentum building
9th Jul 20187:00 amRNSNHS England approves funding for Lojuxta
6th Jul 20187:00 amRNSChange of Registered Address
25th Jun 20188:10 amRNSCompany name alteration for previous release
25th Jun 20187:00 amRNSPositive data of Pollinex Quattro Grass vaccine
5th Jun 201810:41 amRNSResult of AGM
29th May 20187:00 amRNSFour Middle East Lojuxta® Distribution Agreements
10th May 20187:00 amRNSExclusive Lojuxta® Licence Expanded
9th May 20182:48 pmRNSHolding(s) in Company
8th May 20187:00 amRNSHolding(s) in Company and Lock-in agreement
4th May 20187:00 amRNSPosting of Annual Report 2017 and Notice of AGM
17th Apr 20187:00 amRNSFinal Results
15th Mar 20187:00 amRNSTrading update & Gene therapy agreement
6th Mar 20187:00 amRNSSenior Management Appointment
6th Mar 20187:00 amRNSDistribution Agreement for Lojuxta in Middle East
2nd Mar 20187:00 amRNSNotice of Trading Update
30th Jan 20187:00 amRNSNew Distribution Agreement Signed
24th Jan 20187:00 amRNSSenior Management Team Appointment
10th Jan 20187:00 amRNSNew Distribution Agreement Signed
8th Jan 20187:00 amRNSDistribution Agreement Signed Covering Switzerland
20th Dec 20177:00 amRNSSenior Management Team Appointment
1st Dec 20177:00 amRNSGrant of Options & PDMR Dealings
20th Nov 20174:35 pmRNSPrice Monitoring Extension
13th Nov 20177:00 amRNSDistribution Agreement Signed in Saudi Arabia
13th Oct 20173:29 pmRNSHolding(s) in Company
11th Oct 20177:00 amRNSDirector Share Purchases
11th Oct 20177:00 amRNSHolding(s) in Company
11th Oct 20177:00 amRNSEnterprise Securities Market Notice
10th Oct 20177:00 amRNSEnterprise Securities Market Notice
9th Oct 201712:13 pmRNSResult of General Meeting & Completion of Placing
21st Sep 20177:00 amRNSPlacing to raise EUR 15m
4th Sep 20177:00 amRNSInterim Results
31st Aug 20177:00 amRNSAttendance at Rodman & Renshaw Conference
30th Aug 20177:00 amRNSSenior Management Appointment
23rd Aug 20178:30 amRNSNotice of Results
25th Jul 20177:00 amRNSHighly positive long-term study results - Lojuxta
25th May 201711:49 amRNSResult of AGM
25th May 20177:00 amRNSAGM Statement
27th Apr 20177:00 amRNSStudy Results of Real-World Experience of Lojuxta

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.